Huang James
SEC insider (Form 3/4/5 filer). CIK 0001573160. Director at Connect Biopharma Holdings Ltd (CNTB) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on May 29, 2026. Located in SINGAPORE.
Companies Huang James has filed insider reports for
- Connect Biopharma Holdings Ltd (CNTB): Director
- CASI Pharmaceuticals, Inc. (CASI): Director
Huang James
CIK: 0001573160
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
